← Back to Search

Behavioural Intervention

Cranial nerve non-invasive neuromodulation (CN-NINM) for Stroke

N/A

Waitlist Available

Led By Marie-Hélène Milot, Ph.D.

Research Sponsored by Université de Sherbrooke

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up information will be assessed through study completion, an average of 9 months

Awards & highlights

Study Summary

This trial is investigating whether a new brain stimulation technique can help improve motor function and reduce pain in people who have had a stroke.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ information will be assessed through study completion, an average of 9 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~information will be assessed through study completion, an average of 9 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and information will be assessed through study completion, an average of 9 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Adherence to the intervention (training program and CN-NINM) in percent

Dropped out rate of the project in percent and the reasons

Number of participants with CN-NINM-related adverse events as assessed by a questionnaire

+2 more

Secondary outcome measures

Change in UL functional performance on the Wolf Motor Function Test

Change in UL motor function on the Fugl-Meyer Stroke Assessment Scale

Change in affected grip strength on the JAMAR dynamometer

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: strength training interventionExperimental Treatment1 Intervention

Strength training of the affected upper limb in chronic stroke survivors

Group II: Cranial nerve non-invasive neuromodulation (CN-NINM)Experimental Treatment1 Intervention

CN-NINM will be applied during each session of the strength training intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Strength training intervention

2022

N/A

~20

Cranial nerve non-invasive neuromodulation (CN-NINM)

2022

N/A

~20

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Université de SherbrookeLead Sponsor

292 Previous Clinical Trials

69,429 Total Patients Enrolled

8 Trials studying Stroke

1,096 Patients Enrolled for Stroke

Marie-Hélène Milot, Ph.D.Principal InvestigatorUniversité de Sherbrooke

Guillaume Léonard, Ph.D.Principal InvestigatorUniversité de Sherbrooke

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who fits the criteria for involvement in this experiment?

"This medical study is enrolling a dozen individuals aged 18 to 80 who have suffered from stroke. To be eligible, candidates must also fulfil the following prerequisites: advanced in age (18+), gone through post-stroke rehabilitation treatment, present motor recovery on their upper limb, and only experienced one supratentorial stroke episode."

Answered by AI

How many subjects are involved in this research?

"Affirmative. Information obtained from clinicaltrials.gov indicates that this medical trial is still enlisting patients; it was first launched on June 27th 2022 and has since been updated to November 2nd of the same year. There are 12 spots open at a single location for recruitment."

Answered by AI

Are participants still being accepted into this trial?

"According to clinicaltrials.gov, this medical trial is actively seeking participants. It was first announced on June 27th 2022 and the listing has been updated as recently as November 2nd 2022."

Answered by AI

What are the foremost goals of this medical experiment?

"This trial seeks to assess the recruitment rate over a 7 month period, as well as improvement in motor function (as measured by the Fugl-Meyer Stroke Assessment Scale), grip strength (via JAMAR dynamometer tests) and functional performance of the affected upper limb (by Wolf Motor Function Test). A score of 66 on the Fugl-Meyer scale is indicative of full motor recovery."

Answered by AI

Does this research endeavor accept individuals who are over four decades of age?

"The age range of individuals that meet the eligibility criteria for this study is 18 to 80. Notably, there are 37 trials available for those below eighteen and 1007 searching for participants over sixty-five."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Using Cranial Nerve Non-invasive Neuromodulation to Improve Pain and Upper Extremity Function After a Stroke

Marie-Hélène Milot 2022. "Using Cranial Nerve Non-invasive Neuromodulation to Improve Pain and Upper Extremity Function After a Stroke". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05370274.